吸烟不容易得新冠肺炎？这项研究引发了法国的尼古丁禁令_时事

吸烟不容易得新冠肺炎？这项研究引发了法国的尼古丁禁令

最近世界各地做了不少关于新冠肺炎的研究，但是巴黎的一项新研究成功引起了法国政府的注意，并迫使法国政府下令禁止在网上销售尼古丁替代品。这到底是一项什么样的研究呢？

吸烟不容易得新冠肺炎？这项研究引发了法国的尼古丁禁令1 Photo by fotografierende on Unsplash

France on Friday banned online sales of nicotine replacements — such as nicotine gum and patches — after a widely reported Paris study found smokers were less likely to admitted to hospital for COVID-19.

法国于4月24日禁止网上销售尼古丁胶姆糖和尼古丁贴片等尼古丁替代品。此前，巴黎有一项研究被广泛报道，该研究指出吸烟者因感染新冠病毒住院的可能性更低。

In a draft legal text published last week, the government warned there could be a run on nicotine replacements thanks to the study. Pharmacies dispensing treatments for tobacco addiction must limit the amount they issue to an individual patient to a single month's supply.

在上周发布的法律草案中，法国政府警告称，受这项研究影响，国内可能会掀起一阵抢购尼古丁替代品的热潮。配发烟瘾治疗药物的药房给个人患者开出的药量不能超过一个月的剂量。

The text states: "Because of media coverage around the possible protective action of nicotine against Covid-19, there is a strong risk that the dispensing in pharmacies and internet sales of nicotine replacements will experience a surge in the coming days."